Allouche Cyril

Principal Accounting Officer at Revance Therapeutics, Inc.

Sold, on record
$99k
Dollars the filings state
Form 4 sales
6
Latest Mar 18, 2019
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Jul 6 2018

    Sold 393 shares at $28.35 ($11k)

    Allouche Cyril, Principal Financial Officer

    Sold 7.6% of holdings ($146k position)4,750 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Revance Therapeutics, Inc.Unusual
    Nov 9 +126 days

    Sold 2,188 shares at $23.72 ($52k)

    Allouche Cyril, Principal Accounting Officer

    Sold 31.5% of holdings ($165k position)4,750 shares leftFiling

  3. 3 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Nov 20 +11 days

    Sold 491 shares at $20.66 ($10k)

    Allouche Cyril, Principal Accounting Officer

    Sold 10.9% of holdings ($93k position)4,000 shares leftFiling

  4. 4 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Jan 3 +44 days

    Sold 375 shares at $19.48 ($7k)

    Allouche Cyril, Principal Accounting Officer

    Sold 8.6% of holdings ($85k position)4,000 shares left0.8x usual sizeFiling

  5. 5 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Jan 22 +19 days

    Sold 625 shares at $17.77 ($11k)

    Allouche Cyril, Principal Accounting Officer

    Sold 13.5% of holdings ($82k position)4,000 shares left1.4x usual sizeFiling

  6. 6 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Mar 18 +55 days

    Sold 498 shares at $15.48 ($8k)

    Allouche Cyril, Principal Accounting Officer

    Sold 7.2% of holdings ($107k position)6,400 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Allouche Cyril
Source
Mar 18, 2019Revance Therapeutics, Inc.Principal Accounting OfficerForm 4 sale498$8k7.2%Plan not statedSEC
Jan 22, 2019Revance Therapeutics, Inc.Principal Accounting OfficerForm 4 sale625$11k13.5%Plan not statedSEC
Jan 3, 2019Revance Therapeutics, Inc.Principal Accounting OfficerForm 4 sale375$7k8.6%Plan not statedSEC
Nov 20, 2018Revance Therapeutics, Inc.Principal Accounting OfficerForm 4 sale491$10k10.9%Plan not statedSEC
Nov 9, 2018Revance Therapeutics, Inc.Principal Accounting OfficerForm 4 sale2,188$52k31.5%UnusualSEC
Jul 6, 2018Revance Therapeutics, Inc.Principal Financial OfficerForm 4 sale393$11k7.6%Plan not statedSEC